INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
Investigation Announcement: Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Surgery Partners, Inc. and its executives, urging affected investors to reach out for assistance.
Financial Results and Guidance Revision: On November 10, 2025, Surgery Partners reported a decrease in its full-year revenue and adjusted EBITDA guidance, attributing the changes to delays in capital deployment and other operational challenges.
Stock Price Impact: Following the announcement of the revised financial guidance, Surgery Partners' stock price dropped significantly by 25.42%, closing at $16.04 per share.
Pomerantz LLP Background: Pomerantz LLP is a well-established law firm specializing in corporate, securities, and antitrust class litigation, with a history of advocating for victims of securities fraud and corporate misconduct.
Get Free Real-Time Notifications for Any Stock
Analyst Views on SGRY
About SGRY
About the author
Surgery Partners Announces $425 Million Private Debt Offering Pricing
Private Offering Announcement: Surgery Partners (SGRY) announced that its Surgery Center subsidiary has priced a private offering.
Financial Implications: The details regarding the amount raised and the intended use of proceeds from the offering were not specified in the announcement.
Surgery Partners Prices $425 Million Senior Unsecured Notes Offering
- Bond Offering Size: Surgery Partners' wholly-owned subsidiary, Surgery Center Holdings, Inc., has successfully priced $425 million of 7.250% senior unsecured notes, expected to close on December 16, 2025, enhancing the company's financing flexibility.
- Clear Use of Proceeds: The net proceeds from this bond offering will be utilized for general corporate purposes, including repaying outstanding borrowings under its revolving credit facility, thereby optimizing the company's capital structure and reducing financial costs.
- Market Positioning: As a leading healthcare services company in the U.S., Surgery Partners operates over 200 locations across 30 states, continuously expanding its surgical services business to provide high-quality, cost-effective solutions for patients and physicians.
- Compliance and Risk Advisory: This bond offering complies with Rule 144A of the Securities Act, targeting only qualified institutional buyers, and the unregistered securities may face liquidity risks, necessitating attention to market changes that could impact the company's finances.
